Nonpharmacologic stroke prevention in atrial fibrillation

References

• Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch. Intern. Med. 155(5), 469–473 (1995).
   PubMed Web of Science ®Google Scholar
• Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285(18), 2370–2375 (2001).
   PubMed Web of Science ®Google Scholar
• Stewart S, Hart CL, Hole DJ, McMurray JJ. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart 86(5), 516–521 (2001).
   PubMed Web of Science ®Google Scholar
• Majeed A, Moser K, Carroll K. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994–1998: analysis of data from the general practice research database. Heart 86(3), 284–288 (2001).
   PubMed Web of Science ®Google Scholar
• Crystal E, Connolly SJ. Atrial fibrillation: guiding lessons from epidemiology. Cardiol. Clin. 22(1), 1–8 (2004).
   Google Scholar
• Benjamin EJ, Levy D, Vaziri SM et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271(11), 840–844 (1994).
   PubMed Web of Science ®Google Scholar
• Psaty BM, Manolio TA, Kuller LH et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 96(7), 2455–2461 (1997).
   PubMed Web of Science ®Google Scholar
• Ruigomez A, Johansson S, Wallander MA, Rodriguez LA. Incidence of chronic atrial fibrillation in general practice and its treatment pattern. J. Clin. Epidemiol. 55(4), 358–363 (2002).
   PubMed Web of Science ®Google Scholar
• American Heart Association. Heart Disease and Stroke Statistics – 2003 Update. American Heart Association, TX, USA (2003).
   Google Scholar
• Hankey GJ. Stroke: how large a public health problem, and how can the neurologist help? Arch Neurol, 56(6), 748–754 (1999).
   PubMed Web of Science ®Google Scholar
• Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 28(10), 973–977 (1978).
   PubMed Web of Science ®Google Scholar
• Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch. Intern. Med. 154(13), 1449–1457 (1994).
   Google Scholar
• Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22(8), 983–988 (1991).
   PubMed Web of Science ®Google Scholar
• Singer DE, Albers GW, Dalen JE et al. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(Suppl. 3), 429S–456S (2004).
   PubMedGoogle Scholar
• Wang TJ, Massaro JM, Levy D et al. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA 290(8), 1049–1056 (2003).
   PubMed Web of Science ®Google Scholar
• Gage BF, Waterman AD, Shannon W et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285(22), 2864–2870 (2001).
   PubMed Web of Science ®Google Scholar
• Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I–III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Stroke 30(6), 1223–1229 (1999).
   PubMed Web of Science ®Google Scholar
• Gage BF, van Walraven C, Pearce L et al. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 110(16), 2287–2292 (2004).
   PubMed Web of Science ®Google Scholar
• de Denus S, Sanoski CA, Carlsson J, Opolski G, Spinler SA. Rate vs. rhythm control in patients with atrial fibrillation: a meta-analysis. Arch. Intern. Med. 165(3), 258–262 (2005).
   PubMed Web of Science ®Google Scholar
• Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann. Intern. Med. 131(7), 492–501 (1999).
   PubMed Web of Science ®Google Scholar
• Fuster V, Ryden LE, Asinger RW et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the North American Society of Pacing and Electrophysiology. J. Am. Coll. Cardiol. 38(4), 1231–1266 (2001).
   PubMed Web of Science ®Google Scholar
• Carroll K, Majeed A. Comorbidity associated with atrial fibrillation: a general practice-based study. Br. J. Gen. Pract. 51(472), 884–886 (2001).
   Google Scholar
• Bradley BC, Perdue KS, Tisdel KA, Gilligan DM. Frequency of anticoagulation for atrial fibrillation and reasons for its non-use at a Veterans Affairs medical center. Am. J. Cardiol. 85(5), 568–572 (2000).
   PubMed Web of Science ®Google Scholar
• Brass LM, Krumholz HM, Scinto JM, Radford M. Warfarin use among patients with atrial fibrillation. Stroke 28(12), 2382–2389 (1997).
   PubMed Web of Science ®Google Scholar
• Albers GW, Yim JM, Belew KM et al. Status of antithrombotic therapy for patients with atrial fibrillation in university hospitals. Arch. Intern. Med. 156(20), 2311–2316 (1996).
   PubMedGoogle Scholar
• Willems R, Exner DV. Do population studies confirm the benefit of oral anticoagulation in atrial fibrillation demonstrated in clinical trials? J. Interv. Card. Electrophysiol. 10(Suppl. 1), 9–16 (2004).
   Google Scholar
• Evans A, Kalra L. Are the results of randomized controlled trials on anticoagulation in patients with atrial fibrillation generalizable to clinical practice? Arch. Intern. Med. 161(11), 1443–1447 (2001).
   Google Scholar
• Bungard TJ, Ghali WA, Teo KK, McAlister FA, Tsuyuki RT. Why do patients with atrial fibrillation not receive warfarin? Arch. Intern. Med. 160(1), 41–46 (2000).
   Web of Science ®Google Scholar
• Menzin J, Boulanger L, Hauch O et al. Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: a multi-site managed-care study. Ann. Pharmacother. 39(3), 446–451 (2005).
   PubMed Web of Science ®Google Scholar
• Reynolds MW, Fahrbach K, Hauch O et al. Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis. Chest 126(6), 1938–1945 (2004).
   PubMed Web of Science ®Google Scholar
• Ansell J, Hirsh J, Poller L et al. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126(3 Suppl), 204S–233S (2004).
   PubMed Web of Science ®Google Scholar
• Stafford RS, Singer DE. Recent national patterns of warfarin use in atrial fibrillation. Circulation 97(13), 1231–1233 (1998).
   PubMed Web of Science ®Google Scholar
• Go AS, Hylek EM, Borowsky LH et al. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann. Intern. Med. 131(12), 927–934 (1999).
   PubMed Web of Science ®Google Scholar
• Evans A, Davis S, Kilpatrick C et al. The morbidity related to atrial fibrillation at a tertiary centre in one year: 9.0% of all strokes are potentially preventable. J. Clin. Neurosci. 9(3), 268–272 (2002).
   Google Scholar
• Kelly AM, Kerr D, Hew R. Prevention of stroke in chronic and recurrent atrial fibrillation: role of the emergency department in identification of ‘at-risk’ patients. Aust. Health Rev. 24(3), 61–65 (2001).
   Google Scholar
• Cox JL. The surgical treatment of atrial fibrillation. IV. Surgical technique. J. Thorac. Cardiovasc. Surg. 101(4), 584–592 (1991).
   PubMed Web of Science ®Google Scholar
• Cox JL, Boineau JP, Schuessler RB, Jaquiss RD, Lappas DG. Modification of the maze procedure for atrial flutter and atrial fibrillation. I. Rationale and surgical results. J. Thorac. Cardiovasc. Surg. 110(2), 473–484 (1995).
   PubMed Web of Science ®Google Scholar
• Cox JL, Jaquiss RD, Schuessler RB, Boineau JP. Modification of the maze procedure for atrial flutter and atrial fibrillation. II. Surgical technique of the Maze III procedure. J. Thorac. Cardiovasc. Surg. 110(2), 485–495 (1995).
   PubMed Web of Science ®Google Scholar
• Cox JL, Ad N, Palazzo T. Impact of the maze procedure on the stroke rate in patients with atrial fibrillation. J. Thorac. Cardiovasc. Surg. 118(5), 833–840 (1999).
   PubMed Web of Science ®Google Scholar
• Ad N, Cox JL. Stroke prevention as an indication for the Maze procedure in the treatment of atrial fibrillation. Semin. Thorac. Cardiovasc. Surg. 12(1), 56–62 (2000).
   Google Scholar
• Prasad SM, Maniar HS, Camillo CJ et al. The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures. J. Thorac. Cardiovasc. Surg. 126(6), 1822–1828 (2003).
   PubMed Web of Science ®Google Scholar
• Bando K, Kobayashi J, Kosakai Y et al. Impact of Cox maze procedure on outcome in patients with atrial fibrillation and mitral valve disease. J. Thorac. Cardiovasc. Surg. 124(3), 575–583 (2002).
   PubMed Web of Science ®Google Scholar
• Handa N, Schaff HV, Morris JJ et al. Outcome of valve repair and the Cox maze procedure for mitral regurgitation and associated atrial fibrillation. J. Thorac. Cardiovasc. Surg. 118(4), 628–635 (1999).
   PubMed Web of Science ®Google Scholar
• Raanani E, Albage A, David TE, Yau TM, Armstrong S. The efficacy of the Cox/maze procedure combined with mitral valve surgery: a matched control study. Eur. J. Cardiothorac. Surg. 19(4), 438–442 (2001).
   PubMed Web of Science ®Google Scholar
• Kamata J, Kawazoe K, Izumoto H et al. Predictors of sinus rhythm restoration after Cox maze procedure concomitant with other cardiac operations. Ann. Thorac. Surg. 64(2), 394–398 (1997).
   Google Scholar
• Izumoto H, Kawazoe K, Kitahara H, Kamata J. Operative results after the Cox/maze procedure combined with a mitral valve operation. Ann. Thorac. Surg. 66(3), 800–804 (1998).
   PubMed Web of Science ®Google Scholar
• Kosakai Y, Kawaguchi AT, Isobe F et al. Cox maze procedure for chronic atrial fibrillation associated with mitral valve disease. J. Thorac. Cardiovasc. Surg. 108(6), 1049–1054 (1994).
   PubMedGoogle Scholar
• McCarthy PM, Gillinov AM, Castle L, Chung M, Cosgrove D III. The Cox-Maze procedure: the Cleveland Clinic experience. Semin. Thorac. Cardiovasc. Surg. 12(1), 25–29 (2000).
   PubMedGoogle Scholar
• Navia JL, Gillinov AM, McCarthy PM. Curative surgery for atrial fibrillation. Current status and minimally invasive approaches. Minerva Cardioangiol. 52(2), 155–168 (2004).
   Google Scholar
• Arcidi JM Jr, Doty DB, Millar RC. The Maze procedure: the LDS Hospital experience. Semin. Thorac. Cardiovasc. Surg. 12(1), 38–43 (2000).
   PubMedGoogle Scholar
• Kosakai Y. Treatment of atrial fibrillation using the Maze procedure: the Japanese experience. Semin. Thorac. Cardiovasc. Surg. 12(1), 44–52 (2000).
   Google Scholar
• Romano MA, Bach DS, Pagani FD et al. Atrial reduction plasty Cox maze procedure: extended indications for atrial fibrillation surgery. Ann. Thorac. Surg. 77(4), 1282–1287; discussion 1287 (2004).
   Google Scholar
• Raman J, Ishikawa S, Storer MM, Power JM. Surgical radiofrequency ablation of both atria for atrial fibrillation: results of a multicenter trial. J. Thorac. Cardiovasc. Surg. 126(5), 1357–1366 (2003).
   PubMedGoogle Scholar
• Szalay ZA, Civelek A, Dill T et al. Long-term follow-up after the mini-maze procedure. Ann. Thorac. Surg. 77(4), 1277–1281 (2004).
   Google Scholar
• Ad N, Cox JL. The Maze procedure for the treatment of atrial fibrillation: a minimally invasive approach. J. Card. Surg. 19(3), 196–200 (2004).
   PubMed Web of Science ®Google Scholar
• Sie HT, Beukema WP, Elvan A, Ramdat Misier AR. Long-term results of irrigated radiofrequency modified maze procedure in 200 patients with concomitant cardiac surgery: six years experience. Ann. Thorac. Surg. 77(2), 512–516 (2004).
   PubMed Web of Science ®Google Scholar
• Kalil RA, Nesralla PL, Lima GG et al. Assessment of thromboembolism after the Cox-Maze procedure for chronic atrial fibrillation secondary to mitral valve lesion. Arq. Bras. Cardiol. 78(4), 374–381 (2002).
   Google Scholar
• Kobayashi J, Sasako Y, Bando K et al. Eight-year experience of combined valve repair for mitral regurgitation and maze procedure. J. Heart Valve Dis. 11(2), 165–171 (2002).
   Google Scholar
• Schaff HV, Dearani JA, Daly RC, Orszulak TA, Danielson GK. Cox-Maze procedure for atrial fibrillation: Mayo Clinic experience. Semin. Thorac. Cardiovasc. Surg. 12(1), 30–37 (2000).
   Google Scholar
• Nakajima H, Kobayashi J, Bando K et al. The effect of cryo-maze procedure on early and intermediate term outcome in mitral valve disease: case matched study. Circulation 106(12 Suppl. 1), I46–I50 (2002).
   Google Scholar
• Bando K, Kobayashi J, Hirata M et al. Early and late stroke after mitral valve replacement with a mechanical prosthesis: risk factor analysis of a 24-year experience. J. Thorac. Cardiovasc. Surg. 126(2), 358–364 (2003).
   Google Scholar
• Jatene MB, Marcial MB, Tarasoutchi F et al. Influence of the maze procedure on the treatment of rheumatic atrial fibrillation – evaluation of rhythm control and clinical outcome in a comparative study. Eur. J. Cardiothorac. Surg. 17(2), 117–124 (2000).
   Google Scholar
• Deneke T, Khargi K, Grewe PH et al. Efficacy of an additional MAZE procedure using cooled-tip radiofrequency ablation in patients with chronic atrial fibrillation and mitral valve disease. A randomized, prospective trial. Eur. Heart J. 23(7), 558–566 (2002).
   Google Scholar
• Jessurun ER, van Hemel NM, Defauw JJ et al. A randomized study of combining maze surgery for atrial fibrillation with mitral valve surgery. J. Cardiovasc. Surg. (Torino) 44(1), 9–18 (2003).
   Google Scholar
• de Lima GG, Kalil RA, Leiria TL et al. Randomized study of surgery for patients with permanent atrial fibrillation as a result of mitral valve disease. Ann. Thorac. Surg. 77(6), 2089–2094 (2004).
   Google Scholar
• Sueda T, Nagata H, Orihashi K et al. Efficacy of a simple left atrial procedure for chronic atrial fibrillation in mitral valve operations. Ann. Thorac. Surg. 63(4), 1070–1075 (1997).
   PubMed Web of Science ®Google Scholar
• Sueda T, Nagata H, Shikata H et al. Simple left atrial procedure for chronic atrial fibrillation associated with mitral valve disease. Ann. Thorac. Surg. 62(6), 1796–1800 (1996).
   PubMed Web of Science ®Google Scholar
• Takami Y, Yasuura K, Takagi Y et al. Partial maze procedure is effective treatment for chronic atrial fibrillation associated with valve disease. J. Card. Surg. 14(2), 103–108 (1999).
   Google Scholar
• Tuinenburg AE, Van Gelder IC, Tieleman RG et al. Mini-maze suffices as adjunct to mitral valve surgery in patients with preoperative atrial fibrillation. J. Cardiovasc. Electrophysiol. 11(9), 960–967 (2000).
   Google Scholar
• Szalay ZA, Skwara W, Pitschner HF et al. Midterm results after the Mini-Maze procedure. Eur. J. Cardiothorac. Surg. 16(3), 306–311 (1999).
   Google Scholar
• Bauer EP, Szalay ZA, Brandt RR et al. Predictors for atrial transport function after mini-maze operation. Ann. Thorac. Surg. 72(4), 1251–1254 (2001).
   Google Scholar
• Khargi K, Hutten BA, Lemke B, Deneke T. Surgical treatment of atrial fibrillation; a systematic review. Eur. J. Cardiothorac. Surg. 27(2), 258–265 (2005).
   PubMed Web of Science ®Google Scholar
• Cox JL, Ad N, Palazzo T et al. Current status of the Maze procedure for the treatment of atrial fibrillation. Semin. Thorac. Cardiovasc. Surg. 12(1), 15–19 (2000).
   PubMedGoogle Scholar
• Gillinov AM, McCarthy PM. Advances in the surgical treatment of atrial fibrillation. Cardiol. Clin. 22(1), 147–157 (2004).
   Google Scholar
• Doll N, Borger MA, Fabricius A et al. Esophageal perforation during left atrial radiofrequency ablation: is the risk too high? J. Thorac. Cardiovasc. Surg. 125(4), 836–842 (2003).
   Google Scholar
• Haissaguerre M, Jais P, Shah DC et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N. Engl. J. Med. 339(10), 659–666 (1998).
   PubMed Web of Science ®Google Scholar
• Pappone C, Santinelli V. The who, what, why, and how-to guide for circumferential pulmonary vein ablation. J. Cardiovasc. Electrophysiol. 15(10), 1226–1230 (2004).
   Google Scholar
• Cappato R, Calkins H, Chen SA et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 111(9), 1100–1105 (2005).
   PubMed Web of Science ®Google Scholar
• Marrouche NF, Dresing T, Cole C et al. Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: impact of different catheter technologies. J. Am. Coll. Cardiol. 40(3), 464–474 (2002).
   PubMed Web of Science ®Google Scholar
• Hsieh MH, Tai CT, Tsai CF et al. Clinical outcome of very late recurrence of atrial fibrillation after catheter ablation of paroxysmal atrial fibrillation. J. Cardiovasc. Electrophysiol. 14(6), 598–601 (2003).
   Google Scholar
• Pappone C, Rosanio S, Augello G et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J. Am. Coll. Cardiol. 42(2), 185–197 (2003).
   PubMed Web of Science ®Google Scholar
• Gerstenfeld EP, Guerra P, Sparks PB, Hattori K, Lesh MD. Clinical outcome after radiofrequency catheter ablation of focal atrial fibrillation triggers. J. Cardiovasc. Electrophysiol. 12(8), 900–908 (2001).
   PubMed Web of Science ®Google Scholar
• Saad EB, Rossillo A, Saad CP et al. Pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation: functional characterization, evolution, and influence of the ablation strategy. Circulation 108(25), 3102–3107 (2003).
   PubMed Web of Science ®Google Scholar
• Saad EB, Marrouche NF, Saad CP et al. Pulmonary vein stenosis after catheter ablation of atrial fibrillation: emergence of a new clinical syndrome. Ann. Intern. Med. 138(8), 634–638 (2003).
   PubMed Web of Science ®Google Scholar
• Oral H, Scharf C, Chugh A et al. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 108(19), 2355–2360 (2003).
   PubMed Web of Science ®Google Scholar
• Kottkamp H, Tanner H, Kobza R et al. Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions: trigger elimination or substrate modification: early or delayed cure? J. Am. Coll. Cardiol. 44(4), 869–877 (2004).
   PubMed Web of Science ®Google Scholar
• Tsao HM, Chen SA. Evaluation of pulmonary vein stenosis after catheter ablation of atrial fibrillation. Card. Electrophysiol. Rev. 6(4), 397–400 (2002).
   Google Scholar
• Qureshi AM, Prieto LR, Latson LA et al. Transcatheter angioplasty for acquired pulmonary vein stenosis after radiofrequency ablation. Circulation 108(11), 1336–1342 (2003).
   PubMed Web of Science ®Google Scholar
• Pappone C, Oral H, Santinelli V et al. Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation 109(22), 2724–2726 (2004).
   PubMed Web of Science ®Google Scholar
• Al-Saady NM, Obel OA, Camm AJ. Left atrial appendage: structure, function, and role in thromboembolism. Heart 82(5), 547–554 (1999).
   PubMedGoogle Scholar
• Stollberger C, Schneider B, Finsterer J. Elimination of the left atrial appendage to prevent stroke or embolism? Anatomic, physiologic, and pathophysiologic considerations. Chest 124(6), 2356–2362 (2003).
   Google Scholar
• Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann. Thorac. Surg. 61(2), 755–759 (1996).
   PubMed Web of Science ®Google Scholar
• Manning WJ, Weintraub RM, Waksmonski CA et al. Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study. Ann. Intern. Med. 123(11), 817–822 (1995).
   PubMed Web of Science ®Google Scholar
• Manning WJ, Silverman DI, Keighley CS, Oettgen P, Douglas PS. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study. J. Am. Coll. Cardiol. 25(6), 1354–1361 (1995).
   PubMed Web of Science ®Google Scholar
• Leung DY, Black IW, Cranney GB, Hopkins AP, Walsh WF. Prognostic implications of left atrial spontaneous echo contrast in nonvalvular atrial fibrillation. J. Am. Coll. Cardiol. 24(3), 755–762 (1994).
   PubMed Web of Science ®Google Scholar
• Hellerstein HK, Sinaiko E, Dolgin M. Amputation of the Canine Atrial Appendages. Proc. Soc. Exp. Biol. Med. 66(2), 337–337 (1947).
   Google Scholar
• Madden JL. Resection of the left auricular appendix – a prophylaxis for recurrent arterial emboli. JAMA 140(9), 769–772 (1949).
   PubMed Web of Science ®Google Scholar
• Beal JM, Longmire WP, Leake WH. Resection of the auricular appendages. Ann. Surg. 132(3), 517–530 (1950).
   Google Scholar
• Bailey CP, Olsen AK, Keown KK, Nichols HT, Jamison WL. Commissurotomy for mitral stenosis – technique for prevention of cerebral complications. JAMA 149(12), 1085–1091 (1952).
   PubMedGoogle Scholar
• Bonow RO, Carabello B, de Leon AC Jr et al. Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation 98(18), 1949–1984 (1998).
   PubMed Web of Science ®Google Scholar
• Johnson WD, Ganjoo AK, Stone CD, Srivyas RC, Howard M. The left atrial appendage: our most lethal human attachment! Surgical implications. Eur. J. Cardiothorac. Surg. 17(6), 718–722 (2000).
   PubMed Web of Science ®Google Scholar
• Garcia-Fernandez MA, Perez-David E, Quiles J et al. Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. J. Am. Coll. Cardiol. 42(7), 1253–1258 (2003).
   PubMed Web of Science ®Google Scholar
• Frye RL, Kronmal R, Schaff HV, Myers WO, Gersh BJ. Stroke in coronary artery bypass graft surgery: an analysis of the CASS experience. The participants in the Coronary Artery Surgery Study. Int. J. Cardiol. 36(2), 213–221 (1992).
   Google Scholar
• Crystal E, Lamy A, Connolly SJ et al. Left Atrial Appendage Occlusion Study (LAAOS): a randomized clinical trial of left atrial appendage occlusion during routine coronary artery bypass graft surgery for long-term stroke prevention. Am. Heart J. 145(1), 174–178 (2003).
   Google Scholar
• Healey JS, Crystal E, Lamy A et al. Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am. Heart J. (2005) (In Press).
   Google Scholar
• Odell JA, Blackshear JL, Davies E et al. Thoracoscopic obliteration of the left atrial appendage: potential for stroke reduction? Ann. Thorac. Surg. 61(2), 565–569 (1996).
   PubMed Web of Science ®Google Scholar
• Blackshear JL, Johnson WD, Odell JA et al. Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation. J. Am. Coll. Cardiol. 42(7), 1249–1252 (2003).
   Google Scholar
• Sievert H, Lesh MD, Trepels T et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation 105(16), 1887–1889 (2002).
   PubMed Web of Science ®Google Scholar
• Nakai T, Gerstenfeld EP, Lesh MD, Lee RJ. Assessment of the transcatheter left atrial appendage occlusion device for preventing thromboembolism. Am. J. Cardiol. 88(5A), 119G–119G (2001).
   Google Scholar
• Nakai T, Lesh MD, Gerstenfeld EP et al. Percutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism: first experience in canine model. Circulation 105(18), 2217–2222 (2002).
   PubMed Web of Science ®Google Scholar
• Nakai T, Lesh M, Ostermayer S, Billinger K, Sievert H. An endovascular approach to cardioembolic stroke prevention in atrial fibrillation patients. Pacing Clin. Electrophysiol. 26(7 Pt 2), 1604–1606 (2003).
   Google Scholar
• Ostermayer S, Reschke M, Billinger K et al. Percutaneous closure of the left atrial appendage. J. Interv. Cardiol. 16(6), 553–556 (2003).
   PubMedGoogle Scholar
• Omran H, Hardung D, Schmidt H, Hammerstingl C, Luderitz B. Mechanical occlusion of the left atrial appendage. J. Cardiovasc. Electrophysiol. 14(Suppl. 9), S56–S59 (2003).
   Google Scholar
• Hanna IR, Kolm P, Martin R et al. Left atrial structure and function after percutaneous left atrial appendage transcatheter occlusion (PLAATO): six-month echocardiographic follow-up. J. Am. Coll. Cardiol. 43(10), 1868–1872 (2004).
   PubMed Web of Science ®Google Scholar
• Beyard YI, Ostermayer S, Reisman M et al. Occlusion of the left atrial appendage by estheter technique to prevent stroke in patients with atrial fibrillation who can’t take warfarin. Stroke 35(6), E271–E271 (2004).
   Google Scholar
• Bayard YL, Buscheck F, Ostermayer S et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO™) to prevent stroke in patients with atrial fibrillation: interim results of the multicenter feasibility trial. J. Am. Coll. Cardiol. 43(5), 33A–33A (2004).
   Google Scholar
• Poppas A, Nakai T, Sievert H et al. Serial echocardiographic follow-up of percutaneous left atrial appendage transcatheter occlusion (PLAATO™) in patients with atrial fibrillation. J. Am. Coll. Cardiol. 43(5), 348A–349A (2004).
   Google Scholar
• Meier B, Palacios I, Windecker S et al. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc. Interv. 60(3), 417–422 (2003).
   PubMed Web of Science ®Google Scholar
• Schrader R. Indication and techniques of transcatheter closure of patent foramen ovale. J. Interv. Cardiol. 16(6), 543–551 (2003).
   PubMedGoogle Scholar
• Lynch M, Shanewise JS, Chang GL, Martin RP, Clements SD. Recanalization of the left atrial appendage demonstrated by transesophageal echocardiography. Ann. Thorac. Surg. 63(6), 1774–1775 (1997).
   Google Scholar
• Fisher DC, Tunick PA, Kronzon I. Large gradient across a partially ligated left atrial appendage. J. Am. Soc. Echocardiogr. 11(12), 1163–1165 (1998).
   Google Scholar
• Sullivan H, Pollick C. Incomplete left atrial appendage ligation that simulates mitral regurgitation. J. Am. Soc. Echocardiogr. 3(1), 75–77 (1990).
   Google Scholar
• Katz ES, Tsiamtsiouris T, Applebaum RM et al. Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic study. J. Am. Coll. Cardiol. 36(2), 468–471 (2000).
   PubMed Web of Science ®Google Scholar
• Pennec PY, Bezon E, Jobic Y et al. Assessment of two different procedures of left atrial appendage exclusion during cardiac surgery. Eur. Heart J. 24, 431–431 (2003).
   Google Scholar
• Pennec PY, Jobic Y, Blanc JJ, Bezon E, Barra JA. Assessment of different procedures for surgical left atrial appendage exclusion. Ann. Thorac. Surg. 76(6), 2168–2169 (2003).
   Google Scholar
• Stollberger C, Finsterer J, Ernst G, Schneider B. Is left atrial appendage occlusion useful for prevention of stroke or embolism in atrial fibrillation? Z. Kardiol. 91(5), 376–379 (2002).
   Google Scholar
• Zimmerman MB, Blaine EH, Stricker EM. Water intake in hypovolemic sheep: effects of crushing the left atrial appendage. Science 211(4481), 489–491 (1981).
   PubMed Web of Science ®Google Scholar
• Yoshihara F, Nishikimi T, Kosakai Y et al. Atrial natriuretic peptide secretion and body fluid balance after bilateral atrial appendectomy by the maze procedure. J. Thorac. Cardiovasc. Surg. 116(2), 213–219 (1998).
   Google Scholar
• Omari BO, Nelson RJ, Robertson JM. Effect of right atrial appendectomy on the release of atrial natriuretic hormone. J. Thorac. Cardiovasc. Surg. 102(2), 272–279 (1991).
   Google Scholar
• Buresly K, Eisenberg MJ, Zhang X, Pilote L. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction. Arch. Intern. Med. 165(7), 784–789 (2005).
   PubMed Web of Science ®Google Scholar
• Lorenzoni R, Lazzerini G, Cocci F, De Caterina R. Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study. Am. Heart J. 148(1), E6 (2004).
   Google Scholar
• Schneiderman J, Bushi D, Assaf Y et al. Acute efficacy of a new filtration-diversion device at the carotid bifurcation for the prevention of embolic stroke: a swine model. Stroke 34(1), 273–273 (2003).
   Google Scholar
• Harris D, Leor J, Assaf Y et al. Convergence and stabilization of cellular proliferation into steady-state over the permanent arterial filtration struts of the diverter: a novel percutaneous device for protection against embolic stroke. J. Am. Coll. Cardiol. 41(6), 300A–301A (2003).
   Google Scholar
• Tanne D, Nishri B, Oz O et al. The diverter – a novel permanent arterial filtration-diversion device for embolic stroke prevention. Stroke 34(1), 306–307 (2003).
   Google Scholar
• Harris D, Grad Y, Leor J et al. The diverter – a novel endovascular device for stroke prevention by emboli rerouting to the external carotid artery: evaluation in a swine model. Eur. Heart J. 25, 206–206 (2004).
   Google Scholar